Quick Summary:
Advancements in the biotechnology industry present a significant growth opportunity for the global organ-on-chip market. The gradual transition from animal testing models towards a more precise and ethical approach in drug discovery and tissue engineering has led to an increased demand for organ-on-chip devices. These microfluidic cell culture devices enable a realistic simulation of human organ models, which helps in effective drug discovery and testing, thereby making them a cornerstone of precision medicine.
Organ-on-chip devices offer significant advantages such as efficient fluid flow, relevant mechanical cues, and organ level-tissue interface, offering separate access to parenchymal and vascular compartments. This ensures the creation of specific human models with accurate responses at the organ or tissue level. Furthermore, the escalating demand for an alternative to animal testing, coupled with advancements in cell biology, microfabrication, and microfluidics, provides a sustainable growth platform for the organ-on-chip market. The report also highlights key market trends, enlightening potential investors about the opportunities in this growing field.
The global organ-on-chip market size reached US$ 47.0 Million in 2022. Looking forward, the publisher expects the market to reach US$ 266.0 Million by 2028, exhibiting a growth rate (CAGR) of 31.1% during 2023-2028.
Organ-on-chip refers to a microfluidic cell culture device utilized in effective drug discovery of precision medicine and a fast-track prospect of tissue engineering. It helps develop a narrow channel for the blood and airflow in organs, such as the lung, gut, liver, and heart. It enables the creation of a specific human model with functional responses at the organ or tissue level to avoid the usage of animal models. Apart from this, it offers several advantages, such as efficient fluid flow, relevant mechanical cues, an organ-level tissue-tissue interface, and separate access to parenchymal and vascular compartments.
2. What is the expected growth rate of the global organ-on-chip market during 2023-2028?
3. What are the key factors driving the global organ-on-chip market?
4. What has been the impact of COVID-19 on the global organ-on-chip market?
5. What is the breakup of the global organ-on-chip market based on the type?
6. What is the breakup of the global organ-on-chip market based on the application?
7. What is the breakup of the global organ-on-chip market based on the end use?
8. What are the key regions in the global organ-on-chip market?
9. Who are the key players/companies in the global organ-on-chip market?
Organ-on-chip refers to a microfluidic cell culture device utilized in effective drug discovery of precision medicine and a fast-track prospect of tissue engineering. It helps develop a narrow channel for the blood and airflow in organs, such as the lung, gut, liver, and heart. It enables the creation of a specific human model with functional responses at the organ or tissue level to avoid the usage of animal models. Apart from this, it offers several advantages, such as efficient fluid flow, relevant mechanical cues, an organ-level tissue-tissue interface, and separate access to parenchymal and vascular compartments.
Organ-on-chip Market Trends:
There is a currently rise in the demand for organ-on-chips in drug screening to reduce employee healthcare costs; improve employee morale, productivity and performance; and decrease absenteeism, accidents, downtime, turnover, and theft. This, along with the growing demand for lung and kidney-based organ culture devices, represents one of the key factors driving the market. Moreover, there is an increase in the availability of laboratory-engineered functional organs across the globe. This, coupled with the escalating demand for an alternative to animal testing through research activities on organ-on-chip devices for new drug development, is propelling the growth of the market. In addition, the rising adoption of organ-on-chips technology due to advancements in cell biology, microfabrication, and microfluidics is offering lucrative growth opportunities to industry investors. Besides this, the increasing application of organ-on-chips devices in the healthcare industry for real-time imaging, in vitro analysis of biochemical, and genetic and metabolic activities of living cells in a functional tissue are positively influencing the market. Apart from this, key market players are extensively investing in research and development (R&D) activities to develop new solutions and treat pulmonary diseases, which is catalyzing the demand for organ-on-chips technology.Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global organ-on-chip market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on offering, type, application and end use.Breakup by Offering:
- Products
- Services
Breakup by Type:
- Liver
- Heart
- Lung
- Kidney
- Others
Breakup by Application:
- Physiological Model Development
- Drug Discovery
- Toxicology Research
Breakup by End Use:
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Cosmetics Industry
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Allevi Inc., Altis Biosystems, AxoSim, BiomimX S.r.l., Elveflow, Emulate Inc., InSphero, MIMETAS, Nortis Inc., TARA Biosystems Inc. and TissUse GmbH.Key Questions Answered in This Report
1. What was the size of the global organ-on-chip market in 2022?2. What is the expected growth rate of the global organ-on-chip market during 2023-2028?
3. What are the key factors driving the global organ-on-chip market?
4. What has been the impact of COVID-19 on the global organ-on-chip market?
5. What is the breakup of the global organ-on-chip market based on the type?
6. What is the breakup of the global organ-on-chip market based on the application?
7. What is the breakup of the global organ-on-chip market based on the end use?
8. What are the key regions in the global organ-on-chip market?
9. Who are the key players/companies in the global organ-on-chip market?
Frequently Asked Questions about the Global Organ-on-chip Market
What is the estimated value of the Global Organ-on-chip Market?
What is the growth rate of the Global Organ-on-chip Market?
What is the forecasted size of the Global Organ-on-chip Market?
Who are the key companies in the Global Organ-on-chip Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 143 |
| Published | July 2023 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 47 Million |
| Forecasted Market Value ( USD | $ 266 Million |
| Compound Annual Growth Rate | 33.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
Table of Contents
1 Preface3 Executive Summary12 Value Chain Analysis14 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Organ-on-chip Market
6 Market Breakup by Offering
7 Market Breakup by Type
8 Market Breakup by Application
9 Market Breakup by End Use
10 Market Breakup by Region
11 SWOT Analysis
13 Porters Five Forces Analysis
15 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Allevi Inc.
- Altis Biosystems
- AxoSim
- BiomimX S.r.l.
- Elveflow
- Emulate Inc.
- InSphero
- MIMETAS
- Nortis Inc.
- TARA Biosystems Inc.
- TissUse GmbH.
Methodology
LOADING...
